What is the recommended bedtime dose of melatonin (melatonin)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Bedtime Dose of Melatonin

For optimal sleep improvement, melatonin should be dosed based on age and weight: 0.15 mg/kg for children without comorbidities, 3-5 mg for children with psychiatric comorbidities, and 3-5 mg for adults, taken 1.5-2 hours before bedtime. 1

Age-Specific Dosing Recommendations

Children (6-12 years)

  • For children without psychiatric comorbidities, the optimal dose is 0.15 mg/kg body weight (approximately 1.6-4.4 mg depending on weight) 2
  • For children with psychiatric comorbidities (such as ADHD), use fast-release melatonin at 3 mg if <40 kg or 5 mg if >40 kg 2
  • For children with autism spectrum disorders, melatonin at 1-4 mg has shown effectiveness for improving sleep duration, latency, and reducing night wakings 2

Adolescents

  • Similar dosing as for children, with 3-5 mg typically being effective 2
  • Weight-based approach continues to be appropriate in this age group 1

Adults

  • For adults with delayed sleep-wake phase disorder (DSWPD), 5 mg melatonin administered between 19:00-21:00 has shown effectiveness 2
  • For REM sleep behavior disorder, doses may range from 3-15 mg 2
  • For general insomnia in older adults, lower physiological doses (0.3 mg) may be sufficient to restore sleep efficiency 3

Timing of Administration

  • Administer melatonin 1.5-2 hours before habitual bedtime for optimal effect in children 2, 1
  • For adults, administration between 19:00-21:00 has shown effectiveness in studies 2
  • Recent research suggests that taking melatonin 3 hours before desired bedtime may optimize its sleep-promoting effects 4

Formulation Considerations

  • Fast-release melatonin appears more effective than slow-release formulations for sleep onset 2, 5
  • The relative ineffectiveness of slow-release melatonin suggests that a short-lived higher peak concentration works better 5
  • Choose United States Pharmacopeial Convention Verified formulations when possible for more reliable dosing 1

Safety Profile

  • No serious adverse reactions have been documented in relation to melatonin use across age groups 2, 1
  • Common side effects may include:
    • Gastrointestinal upset at higher doses 1
    • Morning sleepiness in some individuals 1
  • Use with caution in patients taking warfarin or those with epilepsy due to potential interactions 1, 5

Dose Optimization Algorithm

  1. Start with lowest effective dose based on age and condition:

    • Children without comorbidities: 0.15 mg/kg 2
    • Children with psychiatric comorbidities: 3 mg (<40 kg) or 5 mg (>40 kg) 2
    • Adults: 3-5 mg 2
  2. Administer 1.5-2 hours before desired bedtime 2, 1

  3. Assess response after 1-2 weeks 1

  4. If ineffective and no adverse effects, consider gradual dose increase within recommended range (up to 15 mg for specific conditions like REM sleep behavior disorder) 2, 1

  5. Doses above 5 mg generally appear no more effective for most sleep disorders 5

Important Clinical Considerations

  • Melatonin is regulated as a dietary supplement, not a medication, raising concerns about purity and reliability of stated doses 1
  • Recent meta-analysis suggests that 4 mg/day may represent the optimal dose for reducing sleep onset latency and increasing total sleep time 4
  • The timing of the melatonin dose is important; if taken too early in the day, it may cause sleepiness and delay adaptation to local time 5
  • Long-term safety data in children is limited, but available evidence is reassuring 1

References

Guideline

Melatonin Safety and Dosing by Age Group

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Melatonin treatment for age-related insomnia.

The Journal of clinical endocrinology and metabolism, 2001

Research

Melatonin for preventing and treating jet lag.

The Cochrane database of systematic reviews, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.